Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mehmet Emin Yılmaz
Observed names:
Mehmet Emın Yılmaz,
Yılmaz, Mehmet Emin
Institutions:
Ankara Onkoloji Eğitim ve Araştırma Hastanesi,
Sağlık Bilimleri Üniversitesi,
Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital,
Gülhane Eğitim ve Araştırma Hastanesi
Observed institutions:
Ankara Onkoloji Eğitim ve Araştırma Hastanesi,
Sağlık Bilimleri Üniversitesi,
Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital,
Gülhane Eğitim ve Araştırma Hastanesi
ORCID:
0000-0002-2361-6591
Observed ORCID:
0000-0002-2361-6591
OpenAlex ID:
A5147448344
Analysis code for "Mucosal, ocular and pulmonary adverse events reported with datopotamab deruxtecan: an indication-restricted disproportionality analysis of the FDA Adverse Event Reporting"
2026
·
Kaya, Osman Bilge
, Karabuğa, Berkan
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
From the stands to survival fandom, a psychosocial force in the fight against cancer
2026
·
Berkan Karabuğa
, Ekin Konca Karabuğa
, et al.
·
Journal of Health Psychology
Analysis code for "Proteogenomic and single-cell dissection of immune heterogeneity in NSMP endometrial cancer reveals dual IDO1 programs"
2026
·
Kaya, Osman bilge
, Karabuga, Berkan
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Real-world effectiveness and safety of brigatinib in advanced ALK-positive NSCLC: a nationwide multicenter study by the Turkish Oncology Group
2026
·
Salih Tunbekici
, Hamit Bal
, et al.
·
Clinical & Translational Oncology
HALP and SII as blood-based predictors in metastatic small-cell lung cancer
2026
·
Berkan Karabuğa
, Mehmet Emin Yılmaz
, et al.
·
Anatolian Current Medical Journal
PDF
Show more works
View as search
Works count:
5
Citation count:
H-index:
I10-index:
Year
Topic
Type